1|Page
NURS 502 FINAL EXAM LATEST 2026-2027 ACTUAL EXAM WITH
COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS (100%
VERIFIED ANSWERS) |ALREADY GRADED A+| ||PROFESSOR
VERIFIED|| ||BRANDNEW!!!||
What types of calcium supplement to recommend - ANSWER-·
Calcium carbonate (take w/ food acid dependent): 40% elemental
calcium
· Calcium citrate (acid independent - take w or w/o food) 21%
elemental calcium
--If on PPI, H2, and elderly (don't produce as much acid) use
calcium citrate
· Calcium gluconate: 9% elemental calcium
** Need to take vitamin D to aide in calcium absorption**
Possible reasons for spotting or breakthrough bleeding during the
menstrual cycle - ANSWER--Missed pills?
-Drug interactions that decrease COC effectiveness ie: AED?
-STDs?
-Cervical/endometrial CA?
-Pregnancy?
,2|Page
-Early cycle bleeding: insufficient estrogen (Day 6-12)
-Late cycle bleeding: insufficient progesterone (Day 16-26)
-Progestin only capsules- ^^ BTB/spotting
Which contraception methods are less effective in women based
on their weight - ANSWER-· Patch: Ortho Evra/Xulane (less
efficacious in women > 90 kg)
· Implants: Implanon/Nexplanon (Women greater than 130% of
IBW excluded from trials)
· Emergency contraception: decreased effectiveness in women w/
higher body weight. Failure rates ^^ for levonorgestrel/ulipristal in
women w/ BMI >30 kg.
Which methods of contraception affect bone mineral density -
ANSWER-Depo-provera (with ^^ duration- use no longer than 2
years, although some studies say OK if pt is tolerating)
Benefits of 24/4 combined hormonal contraceptive pills over 21/7
contraceptive pills - ANSWER-· 24/4 results in greater
suppression of FSH, LH, and estradiol than standard 21/7
,3|Page
formulation - more pituitary ovarian suppression, fewer ovulation
episodes
· Extended cycle: shorten hormone interval to <7 days, decrease
menstrual cycle frequency, + low dose estrogen to the
formulation.
· Continuous cycle: Eliminate hormone interval entirely
Which patient populations should not use combined oral
contraceptives: risk factors - ANSWER-Risks w/ combo: CV
events, lipid effects, DM, migraine HA, cholestatic jaundice,
thromboembolic events
Progestin ONLY indications: Migraine HA, cigarette smoking (Age
>35), Hx VTE, HTN (Vasc dz/age >35), SLE (vasc dz, nephritis,
antiphospholipid ATBs), <3w PP, ^^ TG, CAD, HF,
cerebrovascular dz.
Benefits of 24/4 OCP - ANSWER-**Provides shorter menstrual
periods and fewer menstrual related symptoms such as menstrual
related HA, menorrhagia and anemia
smaller margin of error when pills are missed
, 4|Page
**provide potential advantage of few estrogen related side effects
(nausea, breast tenderness)
**Decreased pill burden, decreased hormone interval
The safety or clinical precautions when prescribing hormone
replacement: RISKS - ANSWER-CHD (^^ risk w/EPT, no effect on
risk w/ ET), breast CA, VTE, endometrial CA (ex. w/ progestin-
PROTECTS against endometrial CA)
The safety or clinical precautions when prescribing hormone
replacement: ABSOLUTE CONTRAINDICATIONS - ANSWER-
Pregnancy, endometrial CA, breast CA, hormone dependent
neoplasm, CHD, CVA/TIA, undx vaginal bleeding, recent/active
vascular thrombus, active/chronic sv liver/GB dz.
The safety or clinical precautions when prescribing hormone
replacement: RELATIVE CONTRAINDICATIONS - ANSWER-
Migraine, Uterine leiomyoma, sz disorder, HTN, XOL (^^TG), hx
vasc thrombus, endometriosis, sv hypocalcemia
NURS 502 FINAL EXAM LATEST 2026-2027 ACTUAL EXAM WITH
COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS (100%
VERIFIED ANSWERS) |ALREADY GRADED A+| ||PROFESSOR
VERIFIED|| ||BRANDNEW!!!||
What types of calcium supplement to recommend - ANSWER-·
Calcium carbonate (take w/ food acid dependent): 40% elemental
calcium
· Calcium citrate (acid independent - take w or w/o food) 21%
elemental calcium
--If on PPI, H2, and elderly (don't produce as much acid) use
calcium citrate
· Calcium gluconate: 9% elemental calcium
** Need to take vitamin D to aide in calcium absorption**
Possible reasons for spotting or breakthrough bleeding during the
menstrual cycle - ANSWER--Missed pills?
-Drug interactions that decrease COC effectiveness ie: AED?
-STDs?
-Cervical/endometrial CA?
-Pregnancy?
,2|Page
-Early cycle bleeding: insufficient estrogen (Day 6-12)
-Late cycle bleeding: insufficient progesterone (Day 16-26)
-Progestin only capsules- ^^ BTB/spotting
Which contraception methods are less effective in women based
on their weight - ANSWER-· Patch: Ortho Evra/Xulane (less
efficacious in women > 90 kg)
· Implants: Implanon/Nexplanon (Women greater than 130% of
IBW excluded from trials)
· Emergency contraception: decreased effectiveness in women w/
higher body weight. Failure rates ^^ for levonorgestrel/ulipristal in
women w/ BMI >30 kg.
Which methods of contraception affect bone mineral density -
ANSWER-Depo-provera (with ^^ duration- use no longer than 2
years, although some studies say OK if pt is tolerating)
Benefits of 24/4 combined hormonal contraceptive pills over 21/7
contraceptive pills - ANSWER-· 24/4 results in greater
suppression of FSH, LH, and estradiol than standard 21/7
,3|Page
formulation - more pituitary ovarian suppression, fewer ovulation
episodes
· Extended cycle: shorten hormone interval to <7 days, decrease
menstrual cycle frequency, + low dose estrogen to the
formulation.
· Continuous cycle: Eliminate hormone interval entirely
Which patient populations should not use combined oral
contraceptives: risk factors - ANSWER-Risks w/ combo: CV
events, lipid effects, DM, migraine HA, cholestatic jaundice,
thromboembolic events
Progestin ONLY indications: Migraine HA, cigarette smoking (Age
>35), Hx VTE, HTN (Vasc dz/age >35), SLE (vasc dz, nephritis,
antiphospholipid ATBs), <3w PP, ^^ TG, CAD, HF,
cerebrovascular dz.
Benefits of 24/4 OCP - ANSWER-**Provides shorter menstrual
periods and fewer menstrual related symptoms such as menstrual
related HA, menorrhagia and anemia
smaller margin of error when pills are missed
, 4|Page
**provide potential advantage of few estrogen related side effects
(nausea, breast tenderness)
**Decreased pill burden, decreased hormone interval
The safety or clinical precautions when prescribing hormone
replacement: RISKS - ANSWER-CHD (^^ risk w/EPT, no effect on
risk w/ ET), breast CA, VTE, endometrial CA (ex. w/ progestin-
PROTECTS against endometrial CA)
The safety or clinical precautions when prescribing hormone
replacement: ABSOLUTE CONTRAINDICATIONS - ANSWER-
Pregnancy, endometrial CA, breast CA, hormone dependent
neoplasm, CHD, CVA/TIA, undx vaginal bleeding, recent/active
vascular thrombus, active/chronic sv liver/GB dz.
The safety or clinical precautions when prescribing hormone
replacement: RELATIVE CONTRAINDICATIONS - ANSWER-
Migraine, Uterine leiomyoma, sz disorder, HTN, XOL (^^TG), hx
vasc thrombus, endometriosis, sv hypocalcemia
